Polymorphism in the Y box controls level of cytokine-mediated expression of HLA-DRB1 genes

Tissue Antigens

Volumn 58, Issue 5, 2001, Pages 315-323

  Sindwani, S ^a   Singal, D P ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

DRB promoter; GM CSF; IFN ; TNF ; X,Y boxes

Indexed keywords

HLA DR ANTIGEN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA POLYMORPHISM; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HAPLOTYPE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE;

BASE SEQUENCE; CELLS, CULTURED; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CONSERVED SEQUENCE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HAPLOTYPES; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035694674     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2001.580505.x     Document Type: Article

References (35)

1. Nomenclature for factors of the HLA system, 1998
2. T-cell tolerance by clonal elimination in the thymus
3. MHC molecules as peptide receptors
4. Quantitative variation in Ia antigen expression plays a central role in immune regulation
5. Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity
6. Constitutive and induced expression of the individual HLA-DR β and α chain loci in different cell types
7. Functional polymorphism of each of the two HLA-DRβ chain loci demonstrated with antigen-specific DR3- and DRw52-restricted T-cell clones
8. Human class II major histocompatibility complex genes and proteins
9. Regulation of major histocompatibility complex class II genes: X, Y and other letters of the alphabet
10. Sequences and factors: A guide to MHC class II transcription
11. Polymorphism in the regulatory regions of HLA-DRB genes correlating with haplotype evolution
12. Polymorphism in the promoter region of HLA-DRB genes
13. Polymorphism in the upstream regulatory regions of HLA-DRB genes
14. Structural and functional analysis of HLA-DRβ promoter polymorphism and isomorphism
15. The different level of expression of HLA-DRB1 and -DRB3 genes is controlled by conserved isotypic differences in promoter sequence
16. Sequence-specific interactions of the nuclear proteins with polymorphic upstream regulatory regions of HLA-DRB genes
17. Differential transcriptional activities of HLA-DR genes in the various haplotypes
18. Polymorphism in the upstream regulatory region and level of expression of HLA-DRB genes
19. Polymorphism in both X and Y box motifs controls level of expression of HLA-DRB1 genes
20. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase
21. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT 1, and TGF-β-regulated expression of the class II activator gene
22. Functional effects of a natural polymorphism in the transcriptional regulatory sequence of HLA-DQB1
23. B-cell specific enhancer activity of conserved upstream elements of the class II major histocompatibility complex DQB genes
24. Mutational analysis of the DRA promoter: Cis-acting sequences and trans-acting factors
25. Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes
26. Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes
27. Differential expression of HLA-DQA1 alleles associated with the promoter polymorphism
28. Differential regulation of HLA-A3 and HLA-B7 MHC class I genes by IFN is due to two nucleotide differences in their IFN response sequence
29. Regulation of MHC class II gene expression
30. Regulation of MHC class I and class II gene transcription: Differences and similarities
31. Mechanisms in organ allograft rejection. An experimental and clinical study
32. Major histocompatibility complex antigens in human liver transplants
33. Lymphokines in autoimmunity - A critical review
34. Comparative study of the role of professional versus semiprofessional or nonprofessional antigen presenting cells in rejection of vascularized organ allografts